FDA Adverse Event Death Summary report: N

AGENT

MDR report key: 22066102 · Received May 21, 2025

Report

Report Number
2124215-2025-32870
Event Type
Death
Date Received
May 21, 2025
Date of Event
January 1, 2024
Report Date
May 21, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
OOB
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DUE TO SAFE HARBOR DEIDENTIFICATION RULES WITH THE REGISTRY DATA OWNER (ACCF), DATA IN THE EVENT DATE AND DATE OF DEATH FIELDS ARE LIMITED TO THE YEAR ONLY. JANUARY 1 OF THE GIVEN YEAR WAS USED TO CAPTURE THIS. UNDER THE TERMS AND CONDITIONS OF THE REGISTRY, ANONYMIZED DATA WAS PROVIDED. NO PRODUCTS WERE RETURNED AS PART OF THE REGISTRY. IT CANNOT BE DETERMINED IF THESE EVENTS HAVE BEEN PREVIOUSLY REPORTED OR IF THE DEVICES WERE RETURNED FOR ANALYSIS AS PART OF A PREVIOUSLY REPORTED SPONTANEOUS COMPLAINT. HOWEVER, THE EVENTS REPORTED WERE ANTICIPATED IN NATURE AS DEFINED BY THE "POTENTIAL ADVERSE EVENTS" LIST IN THE FDA-APPROVED INSTRUCTIONS FOR USE (IFU). DETAILED PRODUCT INFORMATION WAS NOT PROVIDED TO BSC. BECAUSE THE PRODUCT IS UNKNOWN AT THIS TIME, WE ARE UNABLE TO PROVIDE THE COMPLETE UNIQUE IDENTIFIER (UDI) # AND OTHER SPECIFIC PRODUCT INFORMATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE FOLLOWING EVENTS OCCURRED DEATH AT DISCHARGE DECEASED, ACUTE MYOCARDIAL INFARCTION, CARDIAC ARREST, CARDIOGENIC SHOCK, ISCHEMIC STROKE

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
645499 AGENT DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER OOB BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 64 YR Male Death